{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["25(3)"],"submitter":["Wu RR"],"pubmed_abstract":["<b>Aim:</b> Understanding barriers and facilitators to pharmacogenomics (PGx) implementation and how to structure a clinical program with the Veterans Health Administration (VA). <b>Materials & methods:</b> Healthcare provider (HCP) survey at 20 VA facilities assessing PGx knowledge/acceptance and qualitative interviews to understand how best to design and sustain a national program. <b>Results:</b> 186 (12% response rate) surveyed believed PGx informs drug efficacy (74.7%) and adverse events (71.0%). Low confidence in knowledge (43.0%) and ability to implement (35.4-43.5%). 23 (60.5% response rate) interviewees supported a nationally program to oversee VA education, consultation and IT resources. Prescribing HCPs should be directing local activities. <b>Conclusion:</b> HCPs recognize PGx value but are not prepared to implement. Healthcare systems should build system-wide programs for implementation education and support."],"journal":["Pharmacogenomics"],"pagination":["133-145"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10964838"],"repository":["biostudies-literature"],"pubmed_title":["Workforce readiness for pharmacogenomics and key elements for sustainment within the Veterans Health Administration."],"pmcid":["PMC10964838"],"pubmed_authors":["Sperber NR","Burrell TA","Benevent R","Bates JS","Voora D","Villa D","Weeraratne D","Wu RR"],"additional_accession":[]},"is_claimable":false,"name":"Workforce readiness for pharmacogenomics and key elements for sustainment within the Veterans Health Administration.","description":"<b>Aim:</b> Understanding barriers and facilitators to pharmacogenomics (PGx) implementation and how to structure a clinical program with the Veterans Health Administration (VA). <b>Materials & methods:</b> Healthcare provider (HCP) survey at 20 VA facilities assessing PGx knowledge/acceptance and qualitative interviews to understand how best to design and sustain a national program. <b>Results:</b> 186 (12% response rate) surveyed believed PGx informs drug efficacy (74.7%) and adverse events (71.0%). Low confidence in knowledge (43.0%) and ability to implement (35.4-43.5%). 23 (60.5% response rate) interviewees supported a nationally program to oversee VA education, consultation and IT resources. Prescribing HCPs should be directing local activities. <b>Conclusion:</b> HCPs recognize PGx value but are not prepared to implement. Healthcare systems should build system-wide programs for implementation education and support.","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Feb","modification":"2025-04-21T23:48:44.431Z","creation":"2025-04-05T19:19:53.873Z"},"accession":"S-EPMC10964838","cross_references":{"pubmed":["38440834"],"doi":["10.2217/pgs-2023-0193"]}}